Be among trailblazing marketing pros at Brandweek this September 23–26 in Phoenix, Arizona. Experience incredible networking, insightful sessions and a boost of inspiration at ADWEEK’s ultimate brand event. Register by May 13 to save 35%.
Boehringer Ingelheim has awarded WPP’s Mindshare U.S. media duties for its prescription pharmaceuticals business, according to sources.
The client markets brands such as Flomax and Spiriva. The switch will take effect next year.
Boehringer spent about $225 million in measured media for its prescription drugs in 2008, and $155 million for the first 10 months of 2009, per Nielsen.
The incumbent on the business is Havas’ MPG. Sources said the shift is being made without a review.
Last month, the client awarded Mindshare non-U.S.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in